University of Missouri Advances Chemotherapy-Free Treatment for Cancer in Animals and Humans
June 19, 2020
June 19, 2020
COLUMBIA, Missouri, June 19 -- The University of Missouri issued the following news release:
Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exists that are resistant to chemotherapy.
To offer an alternative, Jeffrey Bryan, a professor at the University of Missouri's Co . . .
Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exists that are resistant to chemotherapy.
To offer an alternative, Jeffrey Bryan, a professor at the University of Missouri's Co . . .